Mathieu Els, Direny Abdel N, de Rochars Madsen Beau, Streit Thomas G, Addiss David G, Lammie Patrick J
Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341-3724, USA.
Trop Med Int Health. 2006 Jun;11(6):862-8. doi: 10.1111/j.1365-3156.2006.01626.x.
In the global effort to eliminate lymphatic filariasis, mass drug administrations (MDAs) are organised annually. The success of this strategy depends on achieving high levels of drug coverage, which reduce the number of persons with circulating microfilariae and consequently transmission. Persons who consistently fail to participate in MDAs represent a potential threat to the goal of filariasis elimination. We wanted to know the drug coverage, the proportion of persons who were systematically non-compliant and factors associated with this behaviour.
We conducted three surveys following the third annual MDA of a filariasis elimination program in Leogane, Haiti: (1) a total population survey to determine coverage; (2) an adult survey to determine non-compliance and associated factors and (3) an urban survey to make a rural-urban comparison.
During the third MDA, the overall surveyed coverage was 78.5% [95% confidence interval (CI) 74.4-82.6] A survey among adult population showed coverage estimates for persons >14 years old of 59.4% (95% CI 52.0-66.7), 61.0% (95% CI 55.0-67.4) and 67.3% (95% CI 60.5-74.0), for the first, second and third MDA respectively. The coverage in rural areas (78.3%) was significantly higher than in urban areas (68.3%, P < 0.05). Of the population > 14 years of age, 18% never took the drugs during any of three MDAs. These persons did not differ significantly from MDA participants by age, gender or other characteristics that we assessed.
More research is needed to identify characteristics of systematically non-compliant persons in order to refine health education messages and improve distribution strategies to increase drug coverage.
在全球消除淋巴丝虫病的努力中,每年都会组织大规模药物给药(MDA)。该战略的成功取决于实现高水平的药物覆盖率,这会减少循环微丝蚴感染者的数量,从而减少传播。持续不参与MDA的人群对丝虫病消除目标构成潜在威胁。我们想了解药物覆盖率、系统性不依从者的比例以及与这种行为相关的因素。
在海地莱奥甘的丝虫病消除项目第三次年度MDA之后,我们进行了三项调查:(1)一项总人口调查以确定覆盖率;(2)一项成人调查以确定不依从情况及相关因素;(3)一项城市调查以进行城乡比较。
在第三次MDA期间,总体调查覆盖率为78.5%[95%置信区间(CI)74.4 - 82.6]。对成年人群的一项调查显示,14岁以上人群在第一次、第二次和第三次MDA中的覆盖率估计分别为59.4%(95%CI 52.0 - 66.7)、61.0%(95%CI 55.0 - 67.4)和67.3%(95%CI 60.5 - 74.0)。农村地区的覆盖率(78.3%)显著高于城市地区(68.3%,P < 0.05)。在14岁以上人群中,18%在三次MDA中的任何一次都从未服用过药物。这些人与MDA参与者在年龄、性别或我们评估的其他特征方面没有显著差异。
需要更多研究来确定系统性不依从者的特征,以便完善健康教育信息并改进分发策略,以提高药物覆盖率。